Literature DB >> 27423481

Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitors.

Michael P Dwyer1, Kerry M Keertikar2, Lei Chen2, Ling Tong2, Oleg Selyutin2, Anilkumar G Nair2, Wensheng Yu2, Guowei Zhou2, Brian J Lavey2, De-Yi Yang2, Michael Wong2, Seong Heon Kim2, Craig A Coburn2, Stuart B Rosenblum2, Qingbei Zeng2, Yueheng Jiang2, Bandarpalle B Shankar2, Razia Rizvi2, Amin A Nomeir3, Rong Liu4, Sony Agrawal4, Ellen Xia4, Rong Kong4, Ying Zhai4, Paul Ingravallo4, Ernest Asante-Appiah4, Joseph A Kozlowski2.   

Abstract

A matched and mixed capping SAR study was conducted on the tetracyclic indole class of HCV NS5A inhibitors to examine the influence of modifications of this region on the overall HCV virologic resistance profiles.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Capping; Hepatitis C; Indole; Infectious diseases; NS5A

Mesh:

Substances:

Year:  2016        PMID: 27423481     DOI: 10.1016/j.bmcl.2016.06.063

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  Indole - a promising pharmacophore in recent antiviral drug discovery.

Authors:  Atukuri Dorababu
Journal:  RSC Med Chem       Date:  2020-11-06

2.  In Vitro Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A.

Authors:  Ernest Asante-Appiah; Rong Liu; Stephanie Curry; Patricia McMonagle; Sony Agrawal; Donna Carr; Laura Rokosz; Frederick Lahser; Karin Bystol; Robert Chase; Stuart Black; Eric Ferrari; Paul Ingravallo; Ling Tong; Wensheng Yu; Joseph Kozlowski
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.